LUTETIUM (177LU) ROFAPITIDE TETRAXETAN
UNII T4GK6SP4E2

Substance Identification & Data

This profile provides standardized clinical and technical data for Lutetium (177lu) Rofapitide Tetraxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T4GK6SP4E2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2583700-68-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T4GK6SP4E2

CAS Registry Number

2583700-68-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LUTETIUM (177LU) ROFAPITIDE TETRAXETAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C67H95N13O18S3.Lu.H

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

YSYFTHWGZOTNAV-BSYBIPGTSA-K

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C199069

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

167713251

Unique identification number in the NCBI database of chemical substances.

INN ID

12464

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12cc(CSCCNC(CN3CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC3)=O)cc(CSC[C@H](NC(=O)CCCCC)C(N4CCC[C@H]4C(N5[C@H](C(N[C@@H]([C@H](O)C)C(N[C@@H](CCC(N)=O)C(N[C@H](C(=O)N[C@@H](CSC1)C([O-])=O)Cc6ccccc6)=O)=O)=O)CCC5)=O)=O)c2.[177Lu+3].[H+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lutetium (177lu) Rofapitide Tetraxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LUTETIUM (177LU) ROFAPITIDE TETRAXETAN

Common Names & Synonyms

LUTETIUM (177LU) ROFAPITIDE TETRAXETAN [INN]

Systematic Nomenclature

(2,2',2''-(10-(2-(OXO-.KAPPA.O)-2-((2-((((12S,32S,5R,13R,16S,19S,22S)-19-(3-AMINO-3-OXOPROPYL)-16-BENZYL-13-CARBOXY-5-HEXANAMIDO-22- ((1R)-1-HYDROXYETHYL)-2,4,15,18,21,24-HEXAOXO-7,11- DITHIA-14,17,20,23-TETRAAZA-1(1,2),3(2,1)-DIPYRROLIDINA- 9(1,3)-BENZENACYCLOTETRACOSAPHAN-95- YL)METHYL)SULFANYL)ETHYL)AMINO)ETHYL)-1,4,7,10- TETRAAZACYCLODODECANE-1,4,7-TRIYL- .KAPPA.4N1,N4,N7,N10)TRI(ACETATO-.KAPPA.O))(177LU)LUTETIUM

SYS

(2,2',2''-(10-(2-(OXO-.KAPPA.O)-2-((2-((((12S,32S,5R,13R,16S,19S,22S)-19-(3-AMINO-3-OXOPROPYL)-16-BENZYL-13-CARBOXY-5-HEXANAMIDO-22-((1R)-1-HYDROXYETHYL)-2,4,15,18,21,24-HEXAOXO-7,11-DITHIA-14,17,20,23-TETRAAZA-1(1,2),3(2,1)-DIPYRROLIDINA-9(1,3)-BENZENACYCLOTETRACOSAPHAN-95-YL)METHYL)SULFANYL)ETHYL)AMINO)ETHYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIYL-.KAPPA.4N1,N4,N7,N10)TRI(ACETATO-.KAPPA.O))(177LU)LUTETIUM

SYS

LUTETATE(1-)-177LU, (S-((3-(MERCAPTOMETHYL)-5-(((2-((2-(4,7,10-TRIS((CARBOXY-.KAPPA.O)METHYL)-1,4,7,10-TETRAAZACYCLODODEC-1-YL-.KAPPA.N1,.KAPPA.N4,.KAPPA.N7,.KAPPA.N10)ACETYL-.KAPPA.O)AMINO)ETHYL)THIO)METHYL)PHENYL)METHYL)-N-(1-OXOHEXYL)-L-CYSTEINYL-L-PROLYL-L-PROLYL-L-THREONYL-L-GLUTAMINYL-L-PHENYLALANYL-L-CYSTEINE CYCLIC (1->7)-THIOETHERATO(4-))-, HYDROGEN (1:1)

SYS

External Clinical & Regulatory Resources

Previous UNIIT4GAC6CE83

Next UNIIT4GYX3110D